MoneyWorks4Me

FDC - Quaterly Results

11 Nov 2021 Evaluate
The company witnessed a 5.52% growth in the revenue at Rs. 3962.85 millions for the quarter ended September 2021 as compared to Rs. 3755.38 millions during the year-ago period.Net profit declined -19.28% to Rs. 735.51 millions from Rs. 911.19 millions.A decline of 1027.19 millions was observed in the OP in the quarter ended September 2021 from 1279.15 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 3962.85 3755.38 5.52 8412.47 6816.26 23.42 13254.49 13310.93 -0.42
Other Income 305.76 187.71 62.89 540.10 467.39 15.56 971.46 826.58 17.53
PBIDT 1027.19 1279.15 -19.70 2401.95 2578.70 -6.85 4214.76 3662.37 15.08
Interest 7.17 8.19 -12.45 15.17 15.68 -3.25 34.02 34.15 -0.38
PBDT 1020.02 1270.96 -19.74 2386.78 2563.02 -6.88 4180.74 3628.22 15.23
Depreciation 94.36 95.99 -1.70 189.31 190.13 -0.43 376.23 373.63 0.70
PBT 925.66 1174.97 -21.22 2197.47 2372.89 -7.39 3804.51 3254.59 16.90
TAX 190.15 263.78 -27.91 460.87 555.45 -17.03 859.61 786.81 9.25
Deferred Tax 0.15 -9.22 -101.63 -40.13 -22.55 77.96 14.45 -41.19 -135.08
PAT 735.51 911.19 -19.28 1736.60 1817.44 -4.45 2944.90 2467.78 19.33
Equity 168.81 170.97 -1.26 168.81 170.97 -1.26 168.81 170.97 -1.26
PBIDTM(%) 25.92 34.06 -23.90 28.55 37.83 -24.53 31.80 27.51 15.57
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..